Attached files
| file | filename |
|---|---|
| EX-31.2 - EXHIBIT 31.2 - IMMUNIC, INC. | vtl-123116xexhibit312.htm |
| EX-32.2 - EXHIBIT 32.2 - IMMUNIC, INC. | vtl-123116xexhibit322.htm |
| EX-32.1 - EXHIBIT 32.1 - IMMUNIC, INC. | vtl-123116xexhibit321.htm |
| EX-31.1 - EXHIBIT 31.1 - IMMUNIC, INC. | vtl-123116xexhibit311.htm |
| EX-21.1 - EXHIBIT 21.1 - IMMUNIC, INC. | vtl-123116xexhibit211.htm |
| 10-K - 10-K - IMMUNIC, INC. | vtl-123116x10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We hereby consent to the incorporation by reference in the Registration Statement on S-3 (No. 333-204097) and Registration Statements on Form S-8 (Nos. 333-196571, 333-204644 and 333-211539) of Vital Therapies, Inc. of our report dated March 7, 2017 relating to the financial statements, which appears in this Form 10-K.
/s/ PricewaterhouseCoopers LLP |
San Diego, California |
March 7, 2017 |